Vera Therapeutics (VERA) Profit After Tax (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Profit After Tax came in at -$121.0 million in Q1 2026, down 134.13% YoY from $354.6 million in Q1 2025, and down 32.86% on a QoQ basis from -$91.1 million in Q4 2025.
Vera Therapeutics (VERA) Profit After Tax (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of Profit After Tax data on file, last reported at -$121.0 million in Q1 2026.
- Quarterly Profit After Tax fell 134.13% year-over-year to -$121.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$368.6 million (down 111.88% YoY) and the FY2025 annual result came in at -$299.6 million, down 96.92% from the prior year.
- Profit After Tax retreated to -$121.0 million in Q1 2026, from -$91.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$14.9 million in Q2 2022 to a low of -$121.0 million in Q1 2026.
- A 5-year average of -$44.5 million and a median of -$32.4 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 332.15% — and 2023, when it increased 21.55%.
- Tracing VERA's Profit After Tax over 5 years: stood at -$32.4 million in 2022, then advanced by 21.55% to -$25.4 million in 2023, then tumbled by 70.94% to -$43.4 million in 2024, then slumped by 109.78% to -$91.1 million in 2025, then slumped by 32.86% to -$121.0 million in 2026.
- The last three Profit After Tax figures came in at -$121.0 million (Q1 2026), -$91.1 million (Q4 2025), and -$79.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | -109.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -109.72 Mn |
| Mar 31, 2026 | -121.03 Mn |
| Dec 31, 2025 | -91.10 Mn |
| Sep 30, 2025 | -79.94 Mn |
| Jun 30, 2025 | -76.53 Mn |
| Mar 31, 2025 | -51.69 Mn |
| Dec 31, 2024 | -43.43 Mn |
| Sep 30, 2024 | -45.14 Mn |
| Jun 30, 2024 | -33.71 Mn |
| Mar 31, 2024 | -28.38 Mn |
| Dec 31, 2023 | -25.40 Mn |
| Sep 30, 2023 | -20.10 Mn |
| Jun 30, 2023 | -20.16 Mn |
| Mar 31, 2023 | -30.07 Mn |
| Dec 31, 2022 | -32.38 Mn |
| Sep 30, 2022 | -24.81 Mn |
| Jun 30, 2022 | -14.85 Mn |
| Mar 31, 2022 | -17.09 Mn |
| Dec 31, 2021 | -16.85 Mn |
| Sep 30, 2021 | -7.61 Mn |